These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18202432)
21. Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I. Wong YQ; Binger KJ; Howlett GJ; Griffin MD Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1977-82. PubMed ID: 20133843 [TBL] [Abstract][Full Text] [Related]
22. Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM. Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF Diabetes Metab Syndr; 2017; 11(2):125-131. PubMed ID: 27665027 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of methionine sulphoxide content of ApoA-I in type 2 diabetic patients and young coronaropathic subjects: a preliminary study. Lapolla A; Manzato E; Sartore G; Marin R; Cosma C; Bolis A; Seraglia R; Traldi P Rapid Commun Mass Spectrom; 2011 Jan; 25(2):391-4. PubMed ID: 21192035 [No Abstract] [Full Text] [Related]
24. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients. Soedamah-Muthu SS; Colhoun HM; Taskinen MR; Idzior-Walus B; Fuller JH; Diabetologia; 2000 Nov; 43(11):1353-9. PubMed ID: 11126402 [TBL] [Abstract][Full Text] [Related]
25. Reduced HDL function in children and young adults with type 1 diabetes. Heier M; Borja MS; Brunborg C; Seljeflot I; Margeirsdottir HD; Hanssen KF; Dahl-Jørgensen K; Oda MN Cardiovasc Diabetol; 2017 Jul; 16(1):85. PubMed ID: 28683835 [TBL] [Abstract][Full Text] [Related]
27. Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus. Ohta T; Nishiyama S; Nakamura T; Saku K; Maung KK; Matsuda I Eur J Pediatr; 1998 Apr; 157(4):276-81. PubMed ID: 9578960 [TBL] [Abstract][Full Text] [Related]
29. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus. Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582 [TBL] [Abstract][Full Text] [Related]
30. The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage. White CR; Datta G; Wilson L; Palgunachari MN; Anantharamaiah GM Chem Phys Lipids; 2019 Mar; 219():28-35. PubMed ID: 30707910 [TBL] [Abstract][Full Text] [Related]
31. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice. Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429 [TBL] [Abstract][Full Text] [Related]
32. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721 [TBL] [Abstract][Full Text] [Related]
33. Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes. Jaleel A; Henderson GC; Madden BJ; Klaus KA; Morse DM; Gopala S; Nair KS Diabetes; 2010 Oct; 59(10):2366-74. PubMed ID: 20622162 [TBL] [Abstract][Full Text] [Related]
35. Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes. Valabhji J; Donovan J; McColl AJ; Schachter M; Richmond W; Elkeles RS Diabet Med; 2002 May; 19(5):424-8. PubMed ID: 12027932 [TBL] [Abstract][Full Text] [Related]
36. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus. Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227 [TBL] [Abstract][Full Text] [Related]
37. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant. Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773 [TBL] [Abstract][Full Text] [Related]
38. Plasma lipid transport in the hedgehog: partial characterization of structure and function of apolipoprotein A-I. Sparrow DA; Laplaud PM; Saboureau M; Zhou G; Dolphin PJ; Gotto AM; Sparrow JT J Lipid Res; 1995 Mar; 36(3):485-95. PubMed ID: 7775860 [TBL] [Abstract][Full Text] [Related]
39. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster. Woollett LA; Kearney DM; Spady DK J Lipid Res; 1997 Nov; 38(11):2289-302. PubMed ID: 9392427 [TBL] [Abstract][Full Text] [Related]
40. [Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice]. Julve J; Errico TL; Chen X; Santos D; Freixa J; Porcel I; Cubero E; Escolà-Gil JC; Blanco-Vaca F Clin Investig Arterioscler; 2013; 25(4):164-73. PubMed ID: 23938051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]